TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. March 30, 2001
TCL Archive Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says May 3, 2002
TCL Archive NCI advisors approve recompetition of $62 million phase II contracts program. November 19, 2004